Preparation of enantiopure (R)-flurbiprofen catalyzed by a newly isolated Bacillus cereus C71

Biocatalysis and Biotransformation

Volumn 25, Issue 1, 2007, Pages 29-34

  Qian, Li Li ^a   Chen, Shao Xin ^a   Shi, Bing Zhao ^a  

^a SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY   (China)

Author keywords

Bacillus cereus; Enantioselective hydrolysis; Flurbiprofen; Lipase

Indexed keywords

BACILLUS CEREUS; ENANTIOSELECTIVE HYDROLYSIS; FLURBIPROFEN;

BACTERIA; CATALYSTS; HYDROLYSIS; LIPASES; PH EFFECTS; SURFACE ACTIVE AGENTS; THERMAL EFFECTS;

DRUG PRODUCTS;

2 PROPANOL; ACETONITRILE; ALCOHOL; DIMETHYL SULFOXIDE; FLURBIPROFEN; FLURBIPROFEN ETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; POLYSORBATE 20; POLYSORBATE 40; POLYSORBATE 80; TRIACYLGLYCEROL LIPASE; TRITON X 100; UNCLASSIFIED DRUG;

ARTICLE; BACILLUS CEREUS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIOCATALYST; BIOTECHNOLOGICAL PROCEDURES; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; DRUG HYDROLYSIS; DRUG PURITY; DRUG SYNTHESIS; DRUG TRANSFORMATION; ENANTIOMER; ENANTIOSELECTIVITY; ENZYME SPECIFICITY; NONHUMAN; PROCESS OPTIMIZATION; SOIL MICROFLORA;

BACILLUS CEREUS;

EID: 33947641057     PISSN: 10242422     EISSN: 10292446     Source Type: Journal    
DOI: 10.1080/10242420600792250     Document Type: Article

References (21)

1. Chen, CS, FujimotoY, Girdaukas, G. and Sih, CJ (1982) Quantitative analyses of biochemical kinetic resolution of enantiomers. J Am Chem Soc, 104, pp. 7294-7299.
2. Choi, GS, Kim, JT, Kim, JH, Ryu, YW and Kim, GJ. (2003) Construction and characterization of a recombinant esterase with high activity and enantioselectivity to (S)-ketoprofen ethyl ester. Protein Expr Purif, 29, pp. 85-93.
3. Eriksen, JL, Sagi, SA, Smith, TE, Weggen, S., Das, P., McLendon, DC, Ozols, VV, Jessing, KW, Zavitz, KH, Koo, EH and Golde, TE. (2003) NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aß in vivo. J Clin Invest, 112, pp. 440-449.
4. Giordano, C., Castaldi, G. and Uggeri, F. (1984) Synthesis of anti-inflammatory α-arylalkanoic acids by 1, 2-aryl Shift, new synthetic methods (42). Angew Chem Int Ed Engl, 23, pp. 413-419.
5. Gong, PF, Wu, HY, Xu, JH, Shen, D. and Liu, YY. (2002) Biocatalytic preparation of enantiopure (R)-ketoprofen from its racemic ester by a new yeast isolated Citeromyces matriensis CGMCC0573. Appl Microbiol Biotechnol, 58, pp. 728-734.
6. Gu, QM, Chen, CS and Sih, CJ. (1986) A facile enzymatic resolution process for the preparation of (+)-S-2-(6-hethoxy-2-naphthyl) propionic acid (Naproxen). Tetrahedron Lett, 27, pp. 1763-1766.
7. Hernaiz, MJ, Sanchez-Montero, JM and Sinisterra, JV. (1994) Comparison of the enzymatic activity of commercial and semipurified lipase of Candida cylindracea in the hydrolysis of the esters of (R,S)-2-arylpropionic acids. Tetrahedron, 50, pp. 10749-10760.
8. Kademi, A., Aït-Abdelkader, N., Fakhreddine, L. and Baratti, J. (2000) Characterization of a new thermostable esterase from the moderate thermophilic bacterium Bacillus circulans. J Mol Catal B: Enzym, 10, pp. 395-401.
9. Kim, GJ, Choi, GS, Kim, JY, Lee, JB, Jo, DH and Ryu, YW. (2002) Screening, production and properties of a stereospecific esterase from Pseudomonas sp. S34 with high selectivity to (S)-ketoprofen ethyl ester. J Mol Catal B: Enzym, 17, pp. 29-38.
10. Kosaric, N., Zajic, JE, Aboue, G., Jack, T. and Gerson, D. (1979) Lipase synthesis in hydrocarbon fermentation. Biotechnol Bioeng., 21, pp. 1133-1149.
11. Lalonde, JJ, Govardhan, C., Khalaf, N., Martinez, AG, Visuri, K. and Margolin, AL. (1995) Cross-linked crystals of Candida rugosa lipase: highly efficient catalysts for the resolution of chiral esters. J Am Chem SOC, 117, pp. 6845-6852.
12. Lee, EG, Won, HS and Chung, BH. (2001) Enantioselective hydrolysis of racemic naproxen methyl ester by two-step acetone-treated Candida rugosa lipase. Process Biochem, 37, pp. 293-298.
13. Lee, EG, Won, HS, Ro, HS, Ryu, YW and Chung, BH. (2003) Preparation of enantiomerically pure (S)-flurbiprofen by esterase from Pseudomonas sp. KCTC 10122BP. J Mol Catal B: Enzym, 26, pp. 149-156.
14. Leipold, DD, Kantoci, D., Murray Jr, ED, Quiggle, DD and Wechter, WJ. (2004) Bioinversion of R-flurbiprofen to S-flurbiprofen at various dose levels in rat, mouse, and monkey. Chirality, 16, pp. 379-387.
15. Lotsch, J., Geisslinger, G., Mohammadian, P., Brune, K. and Kobal, G. (1995) Effect of flurbiprofen enantiomers on pain-related chemosomatosensory evoked potentials in human subjects. Brit J Clin Pharmacol, 40, pp. 339-346.
16. Shen, TY. (1972) Perspectives in non-steroidal anti-inflammatory agents. Angew Chem Int Ed Engl, 11, pp. 460-472.
17. Shin, GS, Lee, KW, Kim, TK, Shin, HD and Lee, YH. (2005) Lipase-catalyzed production of optically active (S)-flurbiprofen in aqueous phase reaction system containing chiral succinyl β-cyclodextrin. J Mol Catal B: Enzym, 33, pp. 93-98.
18. Solares, LF, Diaz, M., Brieva, R., Sanchez, VM, Bayod, BM and Gotor, V. (2002) Enzymatic resolution of new carbonate intermediates for the synthesis of (S)-(+)-zopiclone. Tetrahedron Asymmetry, 13, pp. 2577-2582.
19. Terao, Y., Ijima, Y., Kakidani, H. and Ohta, H. (2003) Enzymatic synthesis of (R)-flurbiprofen. Bull Chem Soc Jpn, 76, pp. 2395-2397.
20. Wechter, WJ, Leipold, DD, Murray Jr, ED, Quiggle, DD, McCracken, JD, Barrios, RS and Greenberg, NM. (2000) E-7869 (R-Flurbiprofen) inhibits progression of prostate cancer in the TRAMP Mouse. Cancer Res, 60, pp. 2203-2208.
21. Zhang, HY, Wang, X., Ching, CB and Wu, JC. (2005) Experimental optimization of enzymatic kinetic resolution of racemic flurbiprofen. Biotechnol Appl Biochem, 42, pp. 67-71.